R&D
Female scientist in the lab

Clinical research demands agile CROs

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

Sales & Marketing
12 questions with Dermot Kenny
Sponsored

12 Questions with Dermot Kenny

Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.

Sales & Marketing
pharmaceutical suppliers

Why pharmacies are turning to route optimisation

If the pandemic taught pharmaceutical suppliers anything, it’s the need to be prepared for spikes in demand, as well as ensure the right drugs get to the right people on time.

Market Access
calendar

Is pharma market on the rebound in 2023?

As the financial markets have been roiled by inflation and a minor banking crisis, the pharma industry experienced a period where M&A largely disappeared and investment into biotechs dr

Sales & Marketing

Sales & Marketing
12 questions with Dermot Kenny
Sponsored

12 Questions with Dermot Kenny

Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.

Digital

Market Access

Editor's Picks

  1. AC Immune says Parkinson's drug slows progression
  2. UK confirms lower clawback rate for NHS medicines
  3. Antibiotic is first approval in FDA national priority scheme
  4. Agreement reached on EU's new pharma legislation
  5. UK teams up with Singapore on healthtech regulation

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

R&D
Female scientist in the lab

Clinical research demands agile CROs

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

more